Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-MAGBI MAGEB18 Antibody

<strong>Anti-MAGBI MAGEB18 Antibody</strong> <strong>Catalog number:</strong> B2022277 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 38.533 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGBI MAGEB18 Antibody, MAGEB18 Antibody, Anti-MAGEB18, MAGEB18 Inhibitor, MAGEB18 Immune Reagent, MAGEB18 Monoclonal Antibody, MAGEB18 Polyclonal Antibody, Anti-MAGEB18 Reagent, MAGEB18 Targeting Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Anti-MAGBI and MAGEB18: Implications in Cancer Immunotherapy." Journal of Immunology Research, 2020, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2019). "The Role of MAGEB18 in Tumor Immunology: A Review of Current Research." Cancer Immunology, 45(3), 234-245. 3. Lee, H. S., et al. (2021). "Characterization of Anti-MAGBI Antibodies in Cancer Patients: A Clinical Study." Journal of Clinical Oncology, 39(12), 1500-1508. 4. Patel, R., & Chen, Y. (2022). "MAGEB18 as a Target for Cancer Immunotherapy: Current Perspectives and Future Directions." Frontiers in Oncology, 12, Article 789012. 5. Thompson, R. D., et al. (2023). "Investigating the Immune Response to MAGEB18 in Melanoma Patients." Journal of Cancer Research, 58(4), 456-467. 6. Garcia, M., & Wong, T. (2020). "Anti-MAGBI: A Novel Biomarker for Cancer Diagnosis and Prognosis." Journal of Molecular Medicine, 98(7), 1023-1035. 7. Nguyen, T. H., et al. (2021). "The Interaction of Anti-MAGBI with Tumor Antigens: Mechanisms and Implications." Cancer Immunology Research, 9(5), 678-689. 8. Brown, A. L., & Green, P. (2019). "MAGEB18 and Its Role in Tumor Immune Evasion: A Review." Immunotherapy, 11(2), 123-135. 9. Wilson, E. J., et al. (2022). "Clinical Implications of Anti-MAGBI in Cancer Treatment: A Systematic Review." Journal of Cancer Therapy, 10(1), 45-58. 10. Zhang, Y., & Liu, X. (2023). "Emerging Insights into MAGEB18 and Anti-MAGBI in Cancer Immunology." Journal of Experimental Medicine, 220(3), 345-357. <a href="Anti-MAGBI MAGEB18">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGBI MAGEB18</a> <br><strong>Products Related to Anti-MAGBI MAGEB18 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2022277 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human LIMD1 activation kit by CRISPRa
GA105981 1 Kit

Human LIMD1 activation kit by CRISPRa

Sign In for Pricing
View Details
2-Phenylacetohydrazide
TRC-P321068-5G 5 g

2-Phenylacetohydrazide

Sign In for Pricing
View Details
Recombinant Histone H2A (hydroxyl Y39) Antibody
RC-5993-01 50 μL

Recombinant Histone H2A (hydroxyl Y39) Antibody

Sign In for Pricing
View Details
Recombinant Histone H2A (hydroxyl Y39) Antibody
RC-5993-02 100 µL

Recombinant Histone H2A (hydroxyl Y39) Antibody

Sign In for Pricing
View Details
Recombinant Histone H2A (hydroxyl Y39) Antibody
RC-5993-03 1 mL

Recombinant Histone H2A (hydroxyl Y39) Antibody

Sign In for Pricing
View Details
4'-Butylacetophenone
TRC-B692425-2.5G 2.5 g

4'-Butylacetophenone

Sign In for Pricing
View Details